|Videos|April 11, 2023
Efficacy and Safety of COVID-19 Vaccines in Children
Sean O’Leary, MD, discusses the importance of protection against severe disease vs infection of COVID-19, as well as safety considerations of COVID-19 vaccines in the pediatric population.
Advertisement
Episodes in this series
Advertisement
Related to this article
This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.
Five rapid developments — new mRNA flu vaccine, CDC director, ACIP/NVAC charters, a vaccine order, and an HHS RFI — roil the 2026 schedule.
Court fight over CDC 2026 childhood vaccine schedule shifts shots to shared decision-making; experts warn lower uptake for Hep A, B, flu, COVID.
New evidence supports influenza, COVID-19, and RSV immunizations for reducing severe respiratory illness and hospitalization.
CDC's 2025 NIS-Teen data show HPV vaccine coverage flat for a fourth year, with rural adolescents 12 points behind urban peers in receiving ≥1 dose.
The AAP's 2026-2027 policy recommends universal vaccination for infants 6-23 months and a risk-based single dose for children 2-18 years.
AAP guidance expands RSV immunization eligibility for children aged 8 through 19 months at high risk of severe disease.
Lori Handy, MD, says vaccine conversations with hesitant families should prioritize trust, follow-up, and the benefits for the individual child.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: What's new in IDSA's histoplasmosis treatment guidance?
2
GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds
3
Dietary modulation of gut microbes extends survival in Hirschsprung disease mouse model
4
Predictability may be an overlooked factor in children's mental health
5